Outsourcing Medical Billing: Benefits, Pros and Cons

Outsourcing medical billing may give a practice access to dedicated claims capacity, structured follow-up, specialized workflow knowledge, and clearer reporting. External support can help with charge entry, coding review, claim submission, rejection clearing, denials, authorizations, payment reconciliation, and accounts receivable. For infectious disease practices, the value should be assessed against actual workflows, including office visits, consults, infusions, OPAT, and drug claims.

Potential drawbacks can include less direct control over daily billing activity, added coordination with an external team, dependence on reporting quality, and the need to define responsibilities clearly. A practice may also face challenges if the billing partner does not understand infectious disease workflows, infusion and drug claims, authorization requirements, or payer agreements. Data access, communication, escalation procedures, and oversight should be evaluated before selecting a model.

Start by mapping the current revenue cycle from referral through final payment. Review documentation, coding, eligibility, authorization, charge capture, claims, denials, payment posting, accounts receivable, and contract compliance. Compare internal capacity and observed revenue leakage with the responsibilities an external partner would assume. GrowInfectiousDisease recommends applying the practice’s own numbers and separating verified information from assumptions when evaluating financial sustainability.

Depending on the arrangement, outsourced support may include charge entry, coding review, claim scrubbing, submission, rejection clearing, denial management, payer appeals, eligibility verification, prior authorization, payment reconciliation, underpayment review, and aging accounts receivable follow-up. Some arrangements provide full claims management, while others address overflow or a defined workflow. The scope should be documented so clinical, front-office, coding, and billing responsibilities remain clear.

It can be considered, but the billing model must account for the added complexity of infusion, OPAT, specialty drugs, and buy-and-bill activity. Authorization, medical versus pharmacy benefits, drug and administration charges, documentation, units, and payer contracts may affect reimbursement. A provider should demonstrate familiarity with these workflows and explain how it will report unresolved claims, denials, underpayments, and high-value accounts.

Use reports that show activity by payer, service line, provider, claim status, denial cause, payment pattern, and accounts receivable condition. Compare billed work with expected reimbursement and investigate missing charges, short-pays, rejected claims, and stalled balances. Performance should also be judged by documentation quality, communication, resolution tracking, and whether recurring problems are being traced back to workflow, coding, authorization, or contract causes.

The agreement should clearly define the services included, systems access, data ownership, reporting responsibilities, communication channels, escalation procedures, compliance expectations, and the practice’s role in documentation and approvals. It should also explain how claims, denials, appeals, payment reconciliation, authorizations, and accounts receivable will be handled. Practices should identify how exceptions are documented and how they can review the work performed on their behalf.

It may improve visibility when the external team provides useful reporting and connects findings to specific workflow causes. Reporting can reveal denial patterns, payment trends, aging balances, underpayments, missing charges, and differences among payers, providers, or service lines. Visibility is not automatic, however; the practice should confirm that reports are understandable, based on its own data, and useful for making operational decisions.